No Data
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. subscribed to a 0.2 billion yuan structured deposit product.
Gelonghui reported on January 2 that Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that it recently signed an agreement with Shanghai Pudong Development Bank for structured deposit products, agreeing to subscribe to structured deposit products with a total amount of 0.2 billion yuan using its idle funds generated from daily operations.
Research Reports: CICC: The reforms at Shanghai Pudong Development Bank are starting to show results, maintaining an "outperform industry" rating.
China International Capital Corporation's research report points out that in the past year, Shanghai Pudong Development Bank (600000.SH) has gradually improved its operational efficiency through the implementation of a "Digital Intelligence" Global Strategy, organizational structural transformation, and cultural synergy, resulting in performance improvements. The company is expected to empower its performance through reforms in Technology, human resources, and philosophy. Considering the company is gradually strengthening its detailed management of liabilities, and under the 'symmetrical interest rate reduction' environment, deposit pricing is expected to decline, there is a bullish outlook on the improvement space for the company's funding costs. Taking into account the company’s progressively solidified risk control capabilities and policy support, the expected credit cost is likely to remain at a relatively low level.
Shanghai Pudong Development Bank's (SHSE:600000) 60% Return Outpaced the Company's Earnings Growth Over the Same One-year Period
For the first time in history! The largest Shareholder of Shanghai Pudong Development Bank has increased their Shareholding in the secondary market, and bank stocks with a Low P/b Ratio are attracting capital favor.
① A relevant person from Shanghai Pudong Development Bank confirmed to the Financial Association reporters that the largest Shareholder, International Group, is making its first-ever Shareholding in the bank from the secondary market. ② The market reacted strongly, believing that there are two possible reasons for the Shareholding: implementing Market Cap management and addressing Convertible Bonds issues.
For the first time since 2008? The largest shareholder Shanghai International Group has acted to increase its shareholding in Shanghai Pudong Development Bank, with a maximum limit of 94 million shares, promising not to reduce its shareholding within five
① The company commits not to shareholding the shares it holds in the company during the implementation of this shareholding plan and within 5 years after its completion. ② Wind Statistics show that this shareholding marks the first time Shanghai International Group has increased its holdings in Shanghai Pudong Development Bank in the secondary market after the affiliated company's receipt of a portion of shares transferred from the Shanghai Shibei Group in 2008.
Shanghai Pudong Development Bank (600000.SH): The issuance of the second phase of subordinate capital Bonds in 2024 has been completed.
On December 10, Gelonghui reported that the shanghai pudong development bank (600000.SH) announced that the company's second phase of tier 2 capital bonds for 2024 (hereinafter referred to as "the bonds") has recently been fully issued in the national inter-bank bond market. The bond was booked on December 6, 2024, and completed issuance on December 10, 2024, with a total issuance scale of 40 billion yuan, divided into two varieties. Among them: Variety one is a 10-year fixed-rate bond with a conditional issuer call option at the end of the fifth year, with an issuance scale of 34 billion yuan and a coupon rate of 2.15%; Variety two is a 15-year...
